Wright Medical Group N.V. (NASDAQ: WMGI) recently received a number of ratings updates from brokerages and research firms:

  • 11/3/2017 – Wright Medical Group N.V. had its “buy” rating reaffirmed by analysts at Jefferies Group LLC.
  • 11/2/2017 – Wright Medical Group N.V. had its “hold” rating reaffirmed by analysts at Needham & Company LLC.
  • 11/2/2017 – Wright Medical Group N.V. had its “buy” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $30.00 price target on the stock.
  • 11/2/2017 – Wright Medical Group N.V. had its price target lowered by analysts at BMO Capital Markets from $34.00 to $31.00. They now have an “outperform” rating on the stock.
  • 11/2/2017 – Wright Medical Group N.V. had its price target lowered by analysts at Barclays PLC from $33.00 to $30.00. They now have an “overweight” rating on the stock.
  • 10/12/2017 – Wright Medical Group N.V. had its “buy” rating reaffirmed by analysts at Jefferies Group LLC. They now have a $33.00 price target on the stock.
  • 10/6/2017 – Wright Medical Group N.V. had its “buy” rating reaffirmed by analysts at Robert W. Baird. They now have a $33.00 price target on the stock.
  • 10/3/2017 – Wright Medical Group N.V. had its “buy” rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $31.00 price target on the stock.

Wright Medical Group N.V. (NASDAQ:WMGI) last posted its quarterly earnings data on Wednesday, November 1st. The medical device company reported ($0.16) EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.16). The firm had revenue of $170.50 million during the quarter, compared to analyst estimates of $173.50 million. Wright Medical Group N.V. had a negative net margin of 38.40% and a negative return on equity of 5.99%. The company’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter last year, the business posted ($0.19) EPS.

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Receive News & Ratings for Wright Medical Group NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group NV and related companies with MarketBeat.com's FREE daily email newsletter.